Ensysce Biosciences
ENSC
ENSC
16 hedge funds and large institutions have $3.41M invested in Ensysce Biosciences in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
45% less capital invested
Capital invested by funds: $6.23M → $3.41M (-$2.82M)
Holders
16
Holding in Top 10
–
Calls
$148K
Puts
–
Top Buyers
| 1 | +$62K | |
| 2 | +$59.3K | |
| 3 | +$21K | |
| 4 |
PIA
Powell Investment Advisors
Miami,
Florida
|
+$16.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$28K | |
| 3 | -$13K | |
| 4 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |